Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

DBH gene as predictor of response in a cocaine vaccine clinical trial.

Kosten TR, Domingo CB, Hamon SC, Nielsen DA.

Neurosci Lett. 2013 Apr 29;541:29-33. doi: 10.1016/j.neulet.2013.02.037. Epub 2013 Feb 28.

2.

Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine β-hydroxylase.

Kosten TR, Wu G, Huang W, Harding MJ, Hamon SC, Lappalainen J, Nielsen DA.

Biol Psychiatry. 2013 Feb 1;73(3):219-24. doi: 10.1016/j.biopsych.2012.07.011. Epub 2012 Aug 18.

3.

The κ-opioid receptor gene as a predictor of response in a cocaine vaccine clinical trial.

Nielsen DA, Hamon SC, Kosten TR.

Psychiatr Genet. 2013 Dec;23(6):225-32. doi: 10.1097/YPG.0000000000000008.

4.

The influence of dopamine β-hydroxylase gene polymorphism rs1611115 on levodopa/carbidopa treatment for cocaine dependence: a preliminary study.

Liu S, Green CE, Lane SD, Kosten TR, Moeller FG, Nielsen DA, Schmitz JM.

Pharmacogenet Genomics. 2014 Jul;24(7):370-3. doi: 10.1097/FPC.0000000000000055.

PMID:
24809448
5.

A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity, also associates with cocaine-induced paranoia.

Cubells JF, Kranzler HR, McCance-Katz E, Anderson GM, Malison RT, Price LH, Gelernter J.

Mol Psychiatry. 2000 Jan;5(1):56-63.

PMID:
10673769
6.

Pharmacogenetic randomized trial for cocaine abuse: disulfiram and α1A-adrenoceptor gene variation.

Shorter D, Nielsen DA, Huang W, Harding MJ, Hamon SC, Kosten TR.

Eur Neuropsychopharmacol. 2013 Nov;23(11):1401-7. doi: 10.1016/j.euroneuro.2013.05.014. Epub 2013 Jul 10.

7.

Vaccine for cocaine dependence: a randomized double-blind placebo-controlled efficacy trial.

Kosten TR, Domingo CB, Shorter D, Orson F, Green C, Somoza E, Sekerka R, Levin FR, Mariani JJ, Stitzer M, Tompkins DA, Rotrosen J, Thakkar V, Smoak B, Kampman K.

Drug Alcohol Depend. 2014 Jul 1;140:42-7. doi: 10.1016/j.drugalcdep.2014.04.003. Epub 2014 Apr 16.

8.

Dopamine beta-hydroxylase gene (DbetaH) -1021C-->T influences self-reported paranoia during cocaine self-administration.

Kalayasiri R, Sughondhabirom A, Gueorguieva R, Coric V, Lynch WJ, Lappalainen J, Gelernter J, Cubells JF, Malison RT.

Biol Psychiatry. 2007 Jun 1;61(11):1310-3. Epub 2006 Dec 6.

PMID:
17157269
9.

Cannabis and cocaine decrease cognitive impulse control and functional corticostriatal connectivity in drug users with low activity DBH genotypes.

Ramaekers JG, van Wel JH, Spronk D, Franke B, Kenis G, Toennes SW, Kuypers KP, Theunissen EL, Stiers P, Verkes RJ.

Brain Imaging Behav. 2016 Dec;10(4):1254-1263.

10.

Randomized clinical trial of disulfiram for cocaine dependence or abuse during buprenorphine treatment.

Schottenfeld RS, Chawarski MC, Cubells JF, George TP, Lappalainen J, Kosten TR.

Drug Alcohol Depend. 2014 Mar 1;136:36-42. doi: 10.1016/j.drugalcdep.2013.12.007. Epub 2013 Dec 25.

PMID:
24462581
11.

A genotype-controlled analysis of plasma dopamine beta-hydroxylase in healthy and alcoholic subjects: evidence for alcohol-related differences in noradrenergic function.

Köhnke MD, Zabetian CP, Anderson GM, Kolb W, Gaertner I, Buchkremer G, Vonthein R, Schick S, Lutz U, Köhnke AM, Cubells JF.

Biol Psychiatry. 2002 Dec 15;52(12):1151-8.

PMID:
12488060
12.

Clinical features of methamphetamine-induced paranoia and preliminary genetic association with DBH-1021C→T in a Thai treatment cohort.

Kalayasiri R, Verachai V, Gelernter J, Mutirangura A, Malison RT.

Addiction. 2014 Jun;109(6):965-76. doi: 10.1111/add.12512. Epub 2014 Mar 17.

13.

Spontaneous development of IgM anti-cocaine antibodies in habitual cocaine users: effect on IgG antibody responses to a cocaine cholera toxin B conjugate vaccine.

Orson FM, Rossen RD, Shen X, Lopez AY, Wu Y, Kosten TR.

Am J Addict. 2013 Mar-Apr;22(2):169-74. doi: 10.1111/j.1521-0391.2013.00314.x. Epub 2013 Feb 1.

14.

Vaccine pharmacotherapy for the treatment of cocaine dependence.

Martell BA, Mitchell E, Poling J, Gonsai K, Kosten TR.

Biol Psychiatry. 2005 Jul 15;58(2):158-64.

PMID:
16038686
15.

Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial.

Martell BA, Orson FM, Poling J, Mitchell E, Rossen RD, Gardner T, Kosten TR.

Arch Gen Psychiatry. 2009 Oct;66(10):1116-23. doi: 10.1001/archgenpsychiatry.2009.128.

16.

Association study between the -1021C/T polymorphism of the dopamine-beta-hydroxylase gene promoter and personality traits in healthy subjects.

Kamata M, Suzuki A, Matsumoto Y, Shibuya N, Togashi H, Goto K, Otani K.

Neurosci Lett. 2009 Oct 2;462(1):54-7. doi: 10.1016/j.neulet.2009.06.077. Epub 2009 Jun 26.

PMID:
19560519
17.
18.

Could the inter-individual variability in cocaine-induced psychotic effects influence the development of cocaine addiction? Towards a new pharmacogenetic approach to addictions.

Brousse G, Vorspan F, Ksouda K, Bloch V, Peoc'h K, Laplanche JL, Mouly S, Schmidt J, Llorca PM, Lepine JP.

Med Hypotheses. 2010 Dec;75(6):600-4. doi: 10.1016/j.mehy.2010.07.043.

PMID:
20801583
19.

Genotype-controlled analysis of plasma dopamine beta-hydroxylase activity in psychotic unipolar major depression.

Cubells JF, Price LH, Meyers BS, Anderson GM, Zabetian CP, Alexopoulos GS, Nelson JC, Sanacora G, Kirwin P, Carpenter L, Malison RT, Gelernter J.

Biol Psychiatry. 2002 Mar 1;51(5):358-64.

PMID:
11904129
20.

Human therapeutic cocaine vaccine: safety and immunogenicity.

Kosten TR, Rosen M, Bond J, Settles M, Roberts JS, Shields J, Jack L, Fox B.

Vaccine. 2002 Jan 15;20(7-8):1196-204.

PMID:
11803082

Supplemental Content

Support Center